bioAffinity Technologies (BIAF) Non-cash Items (2022 - 2024)

bioAffinity Technologies has disclosed Non-cash Items across 3 years of filings, most recently posting $243097.0 for Q1 2024.

• In Q1 2024, Non-cash Items fell 10.39% year-over-year to $243097.0; the TTM figure through Mar 2024 stood at $243097.0 (down 10.39% YoY), while the FY2023 annual figure was $158332.0, down 3.61% from the prior year.
• Non-cash Items climbed to $243097.0 in Q1 2024, from $158332.0 in the prior quarter.
• Over the last five years, Non-cash Items for BIAF reached as high as $647793.0 in Q3 2022 and fell as low as $158332.0 in Q4 2023.
• The 3-year median for Non-cash Items is $254225.0 (2023), against an average of $287185.4.
• The widest YoY moves for Non-cash Items: up 3.61% in 2023, down 60.76% in 2023.
• A 3-year view of Non-cash Items shows it stood at $164255.0 in 2022, then decreased by 3.61% to $158332.0 in 2023, then soared by 53.54% to $243097.0 in 2024.
• According to Business Quant data, Non-cash Items over the past three periods registered $243097.0, $158332.0, and $254225.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.